There is no product in the shopping cart, buy it!
| Size | Qty | Add To Basket |
|---|---|---|
| 1 M cells/vial*2 |
| Description | GlycoErase™ SIGLEC12 knockout HepG2 cell line is a human hepatocellular carcinoma cell line lacking SIGLEC12 expression. SIGLEC12, part of the SIGLEC3-like subfamily, contains ITIM and SLAM-like motifs and recruits SHP1/2 phosphatases to inhibit macrophage signaling. The knockout HepG2 system provides a functional model for dissecting inhibitory receptor biology, phosphatase-mediated pathways, and immune regulation in a liver-derived context, with applications in oncology, hepatology, and therapeutic development. |
| Product Type | KO Cell Lines |
| Species | Human |
| Cell Morphology | Epithelial-like, adherent |
| Passage Ratio | 1:4~1:6 |
| Cell Line | HepG2 |
| Primary Disease | Hepatoblastoma |
| Lineage | Liver |
| Lineage Subtype | Hepatoblastoma |
| Cell Viability | >90% |
| Sterility Test | The sterility test indicated an absence of microbial growth. |
| Identity Test | STR identification |
| Mycoplasma Test | Negative |
| Virus Test | Negative for HIV, HBV and HCV. |
| Genetic Stability Testing | We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements. |
| Validation | PCR, Sanger Sequencing |
| Culture Medium | DMEM & FBS & Glutamine |
| Application | Functional assay |
| Size | 1 M cells/vial*2 |
| Product Format | Frozen |
| Shipping | Dry ice |
| Availability Status | Made to order |
| Handling Notes | Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to. |
| Product Disclaimer | This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous. |
| Target | SIGLEC12 |
| Full Name | Sialic Acid Binding Ig Like Lectin 12 |
| Alternative Name | S2V, SLG, SIGLECL1, Siglec-XII, Sialic Acid Binding Ig Like Lectin |
| Location | 19q13.41 |
| Gene ID | 89858 |
| Summary | This gene encodes a member of the SIGLEC3-like subfamily, characterized by an extracellular V-set immunoglobulin-like domain followed by two C2-set domains, and cytoplasmic motifs ITIM and SLAM-like. Upon tyrosine phosphorylation, the protein recruits SHP1 and SHP2, and functions as an inhibitory receptor to negatively regulate macrophage signaling. This gene is clustered with other SIGLEC3-like genes on 19q13.4, and alternative splicing results in multiple transcript variants. |